“The Eyedaptic AR device is game changing, offering a unique solution for those suffering with AMD.” commented Jay Cormier, Eyedaptic co-founder and President.
LAGUNA BEACH, Calif. (PRWEB) June 28, 2018
Eyedaptic, creators of macular degeneration visual aids and simulated natural vision software, will showcase promising Augmented Reality (AR) visual aid prototype, designed to improve reading and everyday tasks in individuals with age-related macular degeneration (AMD). Eyedaptic’s CEO Jay Cormier will speak at the June 29 event, taking place at Fashion Island Hotel in Newport Beach, California.
Age-related macular degeneration (AMD) is the leading cause of vision loss for older individuals, impacting more than 170 million people in the US alone. The number of those impacted by AMD is expected to increase significantly in the next several years, due to our increasing aging population.
Using augmented reality (AR), and their proprietary software, Eyedaptic has developed a non-invasive, mobile visual aid, operating as a pair of high-tech eye glasses. It is designed serve as a practical replacement for low vision devices by completing the user’s field of vision, rather than simply magnify it.
“I am thrilled to present at OCTANE’s Ophthalmology Technology Summit,” commented Jay Cormier, Eyedaptic co-founder and President. “The Eyedaptic AR device is game changing, offering a unique solution for those suffering with AMD.”
Eyedaptic is a privately held company that develops visual aid software, enabled by augmented reality hardware, for macular degeneration and other retinal diseases. The proprietary Simulated Natural Vision software goes beyond magnification to enable a fuller field of vision, for those suffering from central vision disorders such as AMD (age-related macular degeneration), to revitalize their quality of life. For more information or to request an interview, contact: info(at)eyedaptic(dot)com.
OCTANe’s Ophthalmology Technology Summit creates a local forum where leading ophthalmology technologists, researchers, clinicians, and entrepreneurs can come together to discuss ground breaking technologies, unmet clinical needs, and new business opportunities, all to fuel the ophthalmology ecosystem in Southern California. OTS will feature many luminaries in ophthalmology including: Jim Mazzo; Brent Saunders; John Hovanesian, MD, FACS; Ehsan Sadri, MD, FACS; Elizabeth Yeu-Lin, MD; Richard Lindstrom, MD; William Link, PhD, and many more.
For Media Inquiries: